Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Breast Cancer

Free Subscription Articles published in Am J Clin Pathol Retrieve available abstracts of 11 articles: HTML format

Single Articles

November 2025
1. KORIE U, Ai D, Podany P, Zhang H, et al
   Interobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study.
   Am J Clin Pathol. 2025;164:704-711.
   PubMed     Abstract available
   
   
   October 2025
2. CORBIN HN, Neyaz A, Jones TE, Clark BZ, et al
   PRAME immunohistochemistry distinguishes breast secondary angiosarcoma from benign and atypical vascular lesions of the breast.
   Am J Clin Pathol. 2025;164:600-607.
   PubMed     Abstract available
   
   
   September 2025
3. LEE SE, Hsu SC, Hung TH, Ng KF, et al
   Collagenase type IV improves the quality of HER2 fluorescence in situ hybridization for breast cancers.
   Am J Clin Pathol. 2025;164:342-350.
   PubMed     Abstract available
   
   
   August 2025
4. ZILENAITE-PETRULAITIENE D, Rasmusson A, Valkiuniene RB, Laurinaviciene A, et al
   Reproducibility of Ki67 Haralick entropy as a prognostic marker in estrogen receptor-positive HER2-negative breast cancer.
   Am J Clin Pathol. 2025 Aug 9:aqaf081. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2025
5. HUNTER N, Han L, Corbin H, Konnick EQ, et al
   Clinicopathologic and molecular characterization of low-grade, early-stage, and HER2-positive invasive breast carcinoma.
   Am J Clin Pathol. 2025;163:854-865.
   PubMed     Abstract available
   
   
   
6. WILCOCK D, Sirohi D, Coleman JF, Adelhardt P, et al
   HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistry.
   Am J Clin Pathol. 2025;163:837-846.
   PubMed     Abstract available
   
   
   May 2025
7. TSENG YA, Tamayo S, Abada E, Marketkar S, et al
   Interobserver agreement in scoring HER2-negative and HER2-low immunohistochemistry in breast cancer: Reasons for discordance and impact of a single training session.
   Am J Clin Pathol. 2025 May 23:aqaf043. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2025
8. YILDIZ B, Jean-Gilles J Jr, Giampoli EJ, Kovar-Peltz S, et al
   TRPS1 is a useful marker in differentiating metastatic breast carcinoma from pancreatic adenocarcinoma in fine-needle aspiration specimens.
   Am J Clin Pathol. 2025;163:581-585.
   PubMed     Abstract available
   
   
   March 2025
9. XU J, Accola MA, Rehrauer WM, Weisman PS, et al
   Pilomatrix-like breast carcinoma: A mammary analog of pilomatrix-like high-grade endometrioid carcinoma (PiMHEC).
   Am J Clin Pathol. 2025;163:388-394.
   PubMed     Abstract available
   
   
   May 2024
10. HARTSOUGH E, DeSimone MS, Lorenzo ME, Dias-Santagata D, et al
    Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
    Am J Clin Pathol. 2024;161:490-500.
    PubMed     Abstract available
    
    
    
11. KOWALEWSKI A, Klijanienko J
    Cytologic analysis of metaplastic breast carcinoma: Review of 66 cases diagnosed at the Institut Curie.
    Am J Clin Pathol. 2024;161:430-435.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.